Positron emission tomography in neurology and cardiology: a review of guidelines and recommendations
CADTH
Record ID 32014000830
English
Authors' recommendations:
The literature search identified a limited number of guidelines on the use of PET in neurology and cardiology. PET is not recommended for the diagnosis or grading of gliomas, and is recommended in typical cases of dementia and cranial neuropathy where diagnosis remains in doubt after magnetic resonance imaging (MRI) is equivocal or cannot be performed. The use of PET is reasonable to determine the presence of CAD in patients with hypertrophic cardiomyopathy (HCM) with chest discomfort and in patients with acute or chronic heart failure.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/mar-2014/RC0516%20PET%20in%20neurology%20and%20cardiology%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Cardiology
- Neurology
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.